Your browser doesn't support javascript.
The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
Torre, Beatriz G de la; Albericio, Fernando.
  • Torre BG; KRISP, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.
  • Albericio F; School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4001, South Africa.
Molecules ; 26(3)2021 Jan 25.
Article in English | MEDLINE | ID: covidwho-1052505
ABSTRACT
Although the pharmaceutical industry will remember 2020 as the year of COVID-19, it is important to highlight that this year has been the second-best-together with 1996-in terms of the number of drugs accepted by the US Food and Drug Administration (FDA). Each of these two years witnessed the authorization of 53 drugs-a number surpassed only in 2018 with 59 pharmaceutical agents. The 53 approvals in 2020 are divided between 40 new chemical entities and 13 biologic drugs (biologics). Of note, ten monoclonal antibodies, two antibody-drug conjugates, three peptides, and two oligonucleotides have been approved in 2020. Close inspection of the so-called small molecules reveals the significant presence of fluorine atoms and/or nitrogen aromatic heterocycles. This report analyzes the 53 new drugs of the 2020 harvest from a strictly chemical perspective, as it did for those authorized in the previous four years. On the basis of chemical structure alone, the drugs that received approval in 2020 are classified as the following biologics (antibodies, antibody-drug conjugates, and proteins); TIDES (peptide and oligonucleotides); natural products; fluorine-containing molecules; nitrogen aromatic heterocycles; and other small molecules.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: United States Food and Drug Administration / Drug Approval / Drug Industry Type of study: Prognostic study Country/Region as subject: North America Language: English Journal subject: Biology Year: 2021 Document Type: Article Affiliation country: Molecules26030627

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: United States Food and Drug Administration / Drug Approval / Drug Industry Type of study: Prognostic study Country/Region as subject: North America Language: English Journal subject: Biology Year: 2021 Document Type: Article Affiliation country: Molecules26030627